BRITTANY COOPER: Open Payments
NPI 1053042259 · ST FRANCISVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 63 payments from 14 companies in 2025. Trend: 2023 $691 · 2024 $436 · 2025 $909
Food & beverage: $909
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $190 |
| Novo Nordisk Inc | 11 | $148 |
| GlaxoSmithKline, LLC. | 7 | $125 |
| PFIZER INC. | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 5 | $53 |
| Lilly USA, LLC | 2 | $44 |
| Boston Scientific Corporation | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Dexcom, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $39 |
Products named: VRAYLAR, TRELEGY ELLIPTA, ELIQUIS, Wegovy, VOQUEZNA, Ozempic, Rybelsus, Kerendia.
Industry payments across LA — which companies pay providers there.
